A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer Zsuzsanna MihályMáté KormosBalázs Győrffy Review 09 July 2013 Pages: 219 - 232
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials Fausto PetrelliAndrea CoinuSandro Barni Review 17 July 2013 Pages: 233 - 240
Systematic review of radioguided versus wire-guided localization in the treatment of non-palpable breast cancers Muneer AhmedMieke van HemelrijckMichael Douek Review 23 July 2013 Pages: 241 - 252
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study Maria AfentakisMitch DowsettJack Cuzick Preclinical Study 13 July 2013 Pages: 253 - 262
Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast Aram S. A. van BrusselArthur AdamsPaul M. P. van Bergen en Henegouwen Preclinical Study 17 July 2013 Pages: 263 - 272
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice Lu WangYufeng XieJim Xiang Preclinical study 24 July 2013 Pages: 273 - 284
Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time G. L. ChewD. HuangE. W. Thompson Preclinical study 24 July 2013 Pages: 285 - 297
Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients Yasuto NaoiKazuki KishiShinzaburo Noguchi Preclinical study 25 July 2013 Pages: 299 - 306
The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer Hany Onsy HabashyEmad A. RakhaDesmond G. Powe Preclinical study 26 July 2013 Pages: 307 - 316
Lack of circadian variation and reduction of heart rate variability in women with breast cancer undergoing lumpectomy: a descriptive study Melissa V. HansenJacob RosenbergIsmail Gögenur Clinical Trial 17 July 2013 Pages: 317 - 322
Increased expression of Mitotic Arrest Deficient-Like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer Qian SunXianyu ZhangDa Pang Clinical Trial 17 July 2013 Pages: 323 - 330
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer Erica L. MayerM. E. ScheulenM. N. Dickler Clinical Trial 19 July 2013 Pages: 331 - 339
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy Linda T. VahdatAgustin A. GarciaJoseph A. Sparano Clinical trial Open access 23 July 2013 Pages: 341 - 351
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy Andrea L. RussoNils D. ArvoldJay R. Harris Epidemiology 09 July 2013 Pages: 353 - 361
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial V. O. DezentjéR. H. N. van SchaikH.-J. Guchelaar Epidemiology 11 July 2013 Pages: 363 - 373
Tumour diploidy and survival in breast cancer patients with BRCA2 mutations Laufey TryggvadottirElinborg J. OlafsdottirJon G. Jonasson Epidemiology 16 July 2013 Pages: 375 - 384
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study Natalia Garcia-GiraltMaría Rodríguez-SanzXavier Nogués Epidemiology 19 July 2013 Pages: 385 - 395
Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study Stanimira KrotnevaKristen ReidelAri N. Meguerditchian Epidemiology Open access 24 July 2013 Pages: 397 - 405
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study Victoria BlinderSujata PatilRose C. Maly Epidemiology 25 July 2013 Pages: 407 - 416
The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care Sarah L. ElsonRobert A. HiattThe Athena Breast Health Network Epidemiology 26 July 2013 Pages: 417 - 425
The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk Shaneda Warren AndersenAmy Trentham-DietzPolly A. Newcomb Epidemiology 27 July 2013 Pages: 427 - 434
